These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2175241)

  • 1. Decrease in mu-opioid receptor binding capacity in rat brain after chronic PL017 treatment.
    Tao PL; Lee HY; Chang LR; Loh HH
    Brain Res; 1990 Sep; 526(2):270-5. PubMed ID: 2175241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.
    Tao PL; Tsai CL; Chang LR; Loh HH
    Eur J Pharmacol; 1991 Aug; 201(2-3):209-14. PubMed ID: 1665782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in delta-opioid receptor density in rat brain after chronic [D-Ala2,D-Leu5]enkephalin treatment.
    Tao PL; Chang LR; Law PY; Loh HH
    Brain Res; 1988 Oct; 462(2):313-20. PubMed ID: 2847851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
    Tao PL; Law PY; Loh HH
    J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic evidence for decrease in binding of mu- and delta-opioid receptors after subchronic [D-Ala2,D-Leu5]enkephalin treatment in rats.
    Tao PL; Seybold VS; Loh HH
    Eur J Pharmacol; 1993 Feb; 231(2):145-9. PubMed ID: 8384111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of the interaction of mu-opioid receptor and G protein after chronic PL017 treatment in rats.
    Tao PL; Lue WM; Lee CR; Chang LR
    Chin J Physiol; 1995; 38(3):193-9. PubMed ID: 8846729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu opioid receptors participate in the excitatory effect of opiates in the hippocampal slice.
    Bostock E; Dingledine R; Xu G; Chang KJ
    J Pharmacol Exp Ther; 1984 Dec; 231(3):512-7. PubMed ID: 6094789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
    Wong CS; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):317-26. PubMed ID: 1320689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny and distribution of opioid receptors in the rat brainstem.
    Xia Y; Haddad GG
    Brain Res; 1991 May; 549(2):181-93. PubMed ID: 1653081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
    Tavani A; Petrillo P; La Regina A; Sbacchi M
    J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
    Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
    Chang KJ; Wei ET; Killian A; Chang JK
    J Pharmacol Exp Ther; 1983 Nov; 227(2):403-8. PubMed ID: 6313901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternated delta and mu receptor activation: a stratagem for limiting opioid tolerance.
    Russell RD; Kwen-Jen C
    Pain; 1989 Mar; 36(3):381-389. PubMed ID: 2540475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
    Kazmi SM; Mishra RK
    Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
    Roerig SC; Loh HH; Law PY
    Mol Pharmacol; 1992 May; 41(5):822-31. PubMed ID: 1317000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of mu opioid tolerance from receptor down-regulation in rat spinal cord.
    Nishino K; Su YF; Wong CS; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):67-72. PubMed ID: 2158554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15).
    Akiyama K; Gee KW; Mosberg HI; Hruby VJ; Yamamura HI
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2543-7. PubMed ID: 2986120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.